Are Everolimus-Eluting Stents Associated With Better Clinical Outcomes Compared to Other Drug-Eluting Stents in Patients With Type 2 Diabetes Mellitus?: A Systematic Review and Meta-Analysis

Controversies still exist with the use of Everolimus-Eluting Stents (EES) compared to other Drug-Eluting Stents (DES) in patients with Type 2 Diabetes Mellitus (T2DM). Therefore, in order to solve this issue, we aim to compare the 1-year adverse clinical outcomes between EES and non-EE DES with a la...

Descripción completa

Detalles Bibliográficos
Autores principales: Bundhun, Pravesh Kumar, Pursun, Manish, Teeluck, Abhishek Rishikesh, Long, Man-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998804/
https://www.ncbi.nlm.nih.gov/pubmed/27057888
http://dx.doi.org/10.1097/MD.0000000000003276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998804/
https://www.ncbi.nlm.nih.gov/pubmed/27057888
http://dx.doi.org/10.1097/MD.0000000000003276

Ejemplares similares